\begin{table}[htbp]\centering\begin{tabular}{lccc}\hline
Characteristic & Train & Test & P-value \\
\hline
Number of patients & 1362 & 584 & \\

\makecell[l]{Outcome} & $252.68 \pm 410.81$ & $247.47 \pm 405.03$ & 0.797  \\

\makecell[l]{Gender} & 0: 80.6\%, 1: 19.4\% & 0: 82.7\%, 1: 17.3\% & 0.308  \\

\makecell[l]{First Visit Age} & $22.54 \pm 22.28$ & $22.17 \pm 22.07$ & 0.732  \\

\makecell[l]{CI nd U} & 0: 98.8\%, 1: 1.2\% & 0: 99.3\%, 1: 0.7\% & 0.461  \\

\makecell[l]{Lymphocytes Percentage \\ preclinical} & $38.90 \pm 14.86$ & $39.00 \pm 14.92$ & 0.893  \\

\makecell[l]{Lymphocytes Percentage \\ acute} & $33.28 \pm 13.94$ & $33.29 \pm 14.38$ & 0.989  \\

\makecell[l]{Lymphocytes Percentage \\ chronic} & $35.75 \pm 10.23$ & $36.03 \pm 10.92$ & 0.591  \\

\makecell[l]{Neutrophils Percentage \\ acute} & $58.39 \pm 15.23$ & $58.53 \pm 15.71$ & 0.860  \\

\makecell[l]{Neutrophils Percentage \\ preclinical} & $50.32 \pm 16.21$ & $50.26 \pm 16.41$ & 0.941  \\

\makecell[l]{Neutrophils Percentage \\ chronic} & $54.11 \pm 11.02$ & $53.89 \pm 11.89$ & 0.698  \\

\makecell[l]{Monocytes Percentage \\ chronic} & $6.55 \pm 0.91$ & $6.47 \pm 1.08$ & 0.087  \\

\makecell[l]{Monocytes Percentage \\ preclinical} & $6.67 \pm 0.99$ & $6.67 \pm 0.85$ & 0.945  \\

\makecell[l]{Monocytes Percentage \\ acute} & $6.26 \pm 1.12$ & $6.17 \pm 0.96$ & 0.121  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration \\ preclinical} & $343.54 \pm 7.19$ & $343.35 \pm 7.17$ & 0.599  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration acute} & $337.24 \pm 10.47$ & $337.51 \pm 15.82$ & 0.658  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration chronic} & $333.98 \pm 6.32$ & $333.70 \pm 6.92$ & 0.385  \\

\makecell[l]{Platelet Count acute} & $260.60 \pm 66.24$ & $257.48 \pm 66.19$ & 0.341  \\

\makecell[l]{Platelet Count \\ preclinical} & $252.57 \pm 50.35$ & $253.67 \pm 53.74$ & 0.665  \\

\makecell[l]{Platelet Count chronic} & $255.49 \pm 41.71$ & $254.61 \pm 46.73$ & 0.680  \\

\makecell[l]{White Blood Cell Count \\ chronic} & $8.50 \pm 1.56$ & $8.58 \pm 1.80$ & 0.317  \\

\makecell[l]{White Blood Cell Count \\ preclinical} & $8.58 \pm 1.92$ & $8.53 \pm 1.76$ & 0.546  \\

\makecell[l]{White Blood Cell Count \\ acute} & $9.83 \pm 2.95$ & $9.82 \pm 2.73$ & 0.903  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin acute} & $28.59 \pm 1.89$ & $28.61 \pm 2.33$ & 0.860  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin preclinical} & $28.40 \pm 1.65$ & $28.36 \pm 1.76$ & 0.573  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin chronic} & $28.89 \pm 1.53$ & $28.84 \pm 1.63$ & 0.538  \\

\makecell[l]{Mean Corpuscular Volume \\ preclinical} & $82.84 \pm 5.53$ & $82.77 \pm 5.79$ & 0.784  \\

\makecell[l]{Mean Corpuscular Volume \\ chronic} & $86.40 \pm 4.63$ & $86.32 \pm 4.97$ & 0.716  \\

\makecell[l]{Mean Corpuscular Volume \\ acute} & $84.77 \pm 5.92$ & $84.78 \pm 6.44$ & 0.975  \\

\makecell[l]{Hemoglobin chronic} & $130.17 \pm 5.79$ & $129.83 \pm 6.33$ & 0.249  \\

\makecell[l]{Hemoglobin acute} & $129.22 \pm 9.23$ & $128.69 \pm 8.82$ & 0.237  \\

\makecell[l]{Hemoglobin preclinical} & $127.79 \pm 7.18$ & $127.66 \pm 8.31$ & 0.734  \\

\makecell[l]{Eosinophils Percentage \\ acute} & $1.70 \pm 2.12$ & $1.63 \pm 1.99$ & 0.462  \\

\makecell[l]{Eosinophils Percentage \\ preclinical} & $2.81 \pm 2.73$ & $2.68 \pm 2.01$ & 0.314  \\

\makecell[l]{Eosinophils Percentage \\ chronic} & $2.32 \pm 1.60$ & $2.30 \pm 1.49$ & 0.791  \\

\makecell[l]{Basophils Percentage \\ preclinical} & $0.27 \pm 0.13$ & $0.28 \pm 0.14$ & 0.262  \\

\makecell[l]{Basophils Percentage \\ acute} & $0.22 \pm 0.17$ & $0.22 \pm 0.20$ & 0.922  \\

\makecell[l]{Basophils Percentage \\ chronic} & $0.30 \pm 0.16$ & $0.30 \pm 0.18$ & 0.698  \\

\makecell[l]{Absolute Eosinophil \\ Count preclinical} & $0.23 \pm 0.35$ & $0.22 \pm 0.23$ & 0.443  \\

\makecell[l]{Absolute Eosinophil \\ Count acute} & $0.15 \pm 0.22$ & $0.14 \pm 0.17$ & 0.398  \\

\makecell[l]{Absolute Eosinophil \\ Count chronic} & $0.18 \pm 0.14$ & $0.18 \pm 0.13$ & 0.873  \\

\makecell[l]{Absolute Lymphocyte \\ Count chronic} & $2.74 \pm 0.94$ & $2.76 \pm 0.99$ & 0.657  \\

\makecell[l]{Absolute Lymphocyte \\ Count acute} & $2.98 \pm 1.27$ & $3.01 \pm 1.37$ & 0.610  \\

\makecell[l]{Absolute Lymphocyte \\ Count preclinical} & $3.23 \pm 1.35$ & $3.20 \pm 1.35$ & 0.646  \\

\makecell[l]{Mean Platelet Volume \\ acute} & $9.73 \pm 1.14$ & $9.80 \pm 1.13$ & 0.162  \\

\makecell[l]{Mean Platelet Volume \\ preclinical} & $9.53 \pm 0.84$ & $9.56 \pm 0.79$ & 0.476  \\

\makecell[l]{Mean Platelet Volume \\ chronic} & $9.13 \pm 1.01$ & $9.19 \pm 1.04$ & 0.195  \\

\makecell[l]{Platelet Distribution \\ Width acute} & $11.93 \pm 1.92$ & $12.07 \pm 2.05$ & 0.147  \\

\makecell[l]{Platelet Distribution \\ Width chronic} & $12.03 \pm 1.39$ & $12.06 \pm 1.46$ & 0.657  \\

\makecell[l]{Platelet Distribution \\ Width preclinical} & $11.81 \pm 1.51$ & $11.83 \pm 1.52$ & 0.823  \\

\makecell[l]{Eosinophil Count \\ Absolute acute} & $128.49 \pm 129.90$ & $122.98 \pm 124.06$ & 0.386  \\

\makecell[l]{Eosinophil Count \\ Absolute chronic} & $182.08 \pm 116.31$ & $178.04 \pm 102.01$ & 0.466  \\

\makecell[l]{Eosinophil Count \\ Absolute preclinical} & $239.90 \pm 248.52$ & $230.00 \pm 142.53$ & 0.368  \\

\makecell[l]{CR eactive Protein \\ chronic} & $5.80 \pm 6.87$ & $5.76 \pm 6.13$ & 0.889  \\

\makecell[l]{CR eactive Protein \\ preclinical} & $8.85 \pm 6.90$ & $9.01 \pm 8.84$ & 0.667  \\

\makecell[l]{CR eactive Protein \\ acute} & $9.50 \pm 10.14$ & $10.32 \pm 10.72$ & 0.111  \\

\makecell[l]{Immunoglobulin E acute} & $155.75 \pm 114.90$ & $155.27 \pm 97.53$ & 0.930  \\

\makecell[l]{Immunoglobulin E \\ chronic} & $226.93 \pm 348.98$ & $203.50 \pm 152.00$ & 0.119  \\

\makecell[l]{Free Thyroxine chronic} & $16.16 \pm 0.92$ & $16.21 \pm 0.90$ & 0.345  \\

\makecell[l]{Free Thyroxine acute} & $15.36 \pm 0.79$ & $15.36 \pm 0.73$ & 0.860  \\

\makecell[l]{SMRNP chronic} & $1.21 \pm 0.57$ & $1.29 \pm 2.41$ & 0.238  \\

\makecell[l]{SMRNP acute} & $1.33 \pm 0.55$ & $1.37 \pm 0.86$ & 0.230  \\

\makecell[l]{Anti SSA chronic} & $1.32 \pm 2.68$ & $1.35 \pm 3.04$ & 0.810  \\

\makecell[l]{Anti SSA acute} & $1.18 \pm 3.86$ & $1.12 \pm 2.48$ & 0.697  \\

\makecell[l]{Anti Jo 1 chronic} & $1.08 \pm 0.98$ & $1.05 \pm 0.19$ & 0.486  \\

\makecell[l]{Anti Jo 1 acute} & $0.82 \pm 0.44$ & $0.83 \pm 0.44$ & 0.850  \\

\makecell[l]{Nucleosome chronic} & $0.54 \pm 0.44$ & $0.54 \pm 0.43$ & 0.974  \\

\makecell[l]{Nucleosome acute} & $1.14 \pm 0.75$ & $1.15 \pm 0.73$ & 0.725  \\

\makecell[l]{Ribosomal PP rotein \\ chronic} & $1.22 \pm 2.37$ & $1.17 \pm 0.26$ & 0.629  \\

\makecell[l]{Ribosomal PP rotein \\ acute} & $1.09 \pm 0.28$ & $1.08 \pm 0.27$ & 0.430  \\

\makecell[l]{Ro 52 chronic} & $1.83 \pm 2.26$ & $1.88 \pm 3.39$ & 0.703  \\

\makecell[l]{Ro 52 acute} & $1.88 \pm 3.72$ & $1.75 \pm 0.43$ & 0.377  \\
\hline\end{tabular}\caption{Comparison of the characteristics between the training and testing datasets in the time dependent dataset \\ continuous variables are presented as mean Â± standard deviation, categorical variables are presented as number (percentage)} \label{tab:train_test_time}
\end{table}